Original Research

Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison

Hampton P, Borg E, Hansen JB, Augustin M

Psoriasis: Targets and Therapy 2021, 11:123-131

Published Date: 3 November 2021